SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-21-000018
Filing Date
2021-08-05
Accepted
2021-08-05 16:04:56
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20210630.htm   iXBRL 10-Q 913364
2 EX-10.1 exhibit101q221.htm EX-10.1 374846
3 EX-31.1 exhibit311q221.htm EX-31.1 8990
4 EX-31.2 exhibit312q221.htm EX-31.2 9340
5 EX-32.1 exhibit321q221.htm EX-32.1 5240
6 EX-32.2 exhibit322q221.htm EX-32.2 5397
  Complete submission text file 0001657312-21-000018.txt   4287270

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20210630.xsd EX-101.SCH 26746
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20210630_cal.xml EX-101.CAL 52121
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20210630_def.xml EX-101.DEF 60390
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20210630_lab.xml EX-101.LAB 343098
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20210630_pre.xml EX-101.PRE 203349
12 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20210630_htm.xml XML 550771
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 211148105
SIC: 2834 Pharmaceutical Preparations